|
Health care leaders, policymakers, and patients have learned many lessons during the Covid-19 pandemic. Americans have benefitted from temporary regulatory relief that expanded access to popular services like telehealth. Meanwhile, policies like a “public option,” drug price controls and drug importation schemes were debated for the negative impact they would have on America’s health care during a pandemic.
This panel will feature PRI’s health care experts discussing free market health care policy changes that should be made permanent following the pandemic and exploring the latest on the development and distribution of Covid-19 vaccines and therapeutics and future policy implications. The panel will also discuss why embracing entrepreneurship in health care is key to helping the economic recovery post-pandemic, lowering health care costs, and increasing access to innovative care.
Speakers:
- Sally Pipes, PRI President, CEO, and Thomas W. Smith Fellow in Health Care Policy
- Wayne Winegarden, senior fellow in business and economics and director of the Center for Medical Economics and Innovation, Pacific Research Institute
- Henry Miller, senior fellow in health studies, Pacific Research Institute
|
